申请人:The Upjohn Company
公开号:US04077844A1
公开(公告)日:1978-03-07
Bioconversion of the antibiotic steffimycinone to the antibiotic steffimycinol. Steffimycinol is active against various microorganisms, for example, Bacillus subtilis, Mycobacterium avium and Streptococcus pyogenes. Steffimycinol is converted to 7-deoxysteffimycinol by a microaerophilic Aeromonas hydrophila fermentation. 7-Deoxysteffimycinol is active against Sarcina lutea, Bacillus cereus, and B. subtilis. Thus, there antibiotics can be used to inhibit the growth of the above microorganisms in various environments.
青霉素类抗生素steffimycinone的生物转化为青霉素类抗生素steffimycinol。Steffimycinol对各种微生物具有活性,例如枯草芽孢杆菌,肺结核分枝杆菌和链球菌。微氧性水生单胞菌发酵将Steffimycinol转化为7-去氧Steffimycinol。7-去氧Steffimycinol对黄色葡萄球菌,蜡样芽孢杆菌和枯草芽孢杆菌具有活性。因此,这些抗生素可以用于抑制上述微生物在各种环境中的生长。